-
Annexon Inc. NASDAQ:ANNX Annexon, Inc., doing business as Annexon Biosciences, operates as a clinical-stage biopharmaceutical company. The Company develops novel therapies for auto-immune and neurodegenerative diseases of body, eye, and brain. Annexon Biosciences serves patients in the State of California.
Location: | Website: www.annexonbio.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
330.3M
Cash
368.7M
Avg Qtr Burn
-25.44M
Short % of Float
11.29%
Insider Ownership
0.50%
Institutional Own.
-
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ANX005 (IV) Details Guillian-Barre syndrome, Autoimmune disease | BLA Submission | |
ANX007 (IVT) Details Geographic atrophy | Phase 3 Data readout | |
ANX005 (IV) Details Brain disease, Huntington's disease | Phase 3 Initiation | |
ANX005 (IV) Details Amyotrophic lateral sclerosis, Neurodegenerative disease | Phase 2a Update | |
ANX009 Details Lupus nephritis | Phase 1b Update | |
ANX105 Details Autoimmune disease, Neurodegenerative disease | Phase 1 Data readout | |
ANX1502 Details Autoimmune disease, Cold agglutinin disease | Phase 1a Data readout | |
ANX005 (IV) Details Warm autoimmune hemolytic anemia, Autoimmune disease | Failed Discontinued |